Overview Efficacy of an Intranasal Testosterone Product Status: Completed Trial end date: 2010-12-01 Target enrollment: Participant gender: Summary This clinical trial will compare the pharmacokinetic profile of testosterone after repeated intranasal administration of TBS-1 of different strengths in subjects with hypogonadism Phase: Phase 2 Details Lead Sponsor: Acerus Pharmaceuticals CorporationTrimel Biopharma SRLTreatments: MethyltestosteroneTestosteroneTestosterone 17 beta-cypionateTestosterone enanthateTestosterone undecanoate